Enantioconvergent Baeyer–Villiger Oxidation
FULL PAPERS
see: A. Watanabe, T. Uchida, R. Irie, T. Katsuki, Proc.
Natl. Acad. Sci. USA 2004, 101, 5737–5742.
[18] Because we used whole cells, it is not possible to distin-
guish between a real inhibitory effect (depending on the
enzyme) and a toxic effect (depending on the cell). In
this paper, we use the term of “inhibition” only to
make the reading easier.
[19] For racemisation of ketonic compounds, see: a) Y. Xie,
H. Liu, J. Chen, Int. J. Pharm. 2000, 196, 21–26; b) C.-
Y. Chen, Y.-S. Chang, S.-A. Lin, H.-I. Wen, Y.-C. Cheng,
S.-W. Tsai, J. Org. Chem. 2002, 67, 3323–3326; c) R. Val-
carce, G. G. Smith, Chemom. Intell. Lab. Syst. 1992, 16,
61–68; d) M. Aurelly, G. Lamaty, Bull. Soc. Chim. Fr.
1980, 7–8, 389–394.
[20] For other racemisations, see: a) K. Kawamura, M. Yukio-
ka, Thermochim. Acta 2001, 9–16; b) M. A. Wegman,
M. A. P. J. Hacking, J. Rops, P. Pereira, F. van Rantwijk,
R. A. Sheldon, Tetrahedron: Asymmetry 1999, 10,
1739–1750; c) M. Reist, P.-A. Carrupt, B. Testa, S. Leh-
mann, J. J. Hansen, Helv. Chim. Acta, 1996, 79, 767–
778; d) A. R. Bassindale, J. C. Y. Lau, P. G. Taylor, J. Or-
ganomet. Chem. 1995, 490, 75–82.
[21] E. J. Ebbers, G. J. A. Ariaans, J. P. M. Houbiers, A. Brug-
gink, B. Zwanenburg, Tetrahedron 1997, 53, 9417–9476.
[22] M. Studer, H.-U. Blaser, S. Burkhardt, Adv. Synth. Catal.
2002, 344, 511–515.
[23] a) F. Wagner, C. Syldatk, M. Pietzsch, (Degussa Compa-
ny), European Patent EP 0542098, 1995; b) M. Inagaki, J.
Hiratake, T. Nishioka, J. Oda, J. Org. Chem. 1992, 57,
5643–5649.
[24] To check a possible involvement of this functionality, we
studied racemisation adding 5 equivalents of NEt3 but
the racemisation rate (krac ¼0.067 h–1 for a pH of 7.7)
was similar to that observed in absence of resin.
[25] All our attempts to measure independently the propor-
tions of both forms failed because the equilibrium was
modified by the conditions of analysis (GC or HPLC).
[26] R. M. Kitamura, M. Tokunaga, R. Noyori, Tetrahedron
1993, 49, 1853–1860.
[9] a) N. M. Kamerbeek, D. B. Janssen, W. J. H. van Berkel,
M. W. Fraaije, Adv. Synth. Catal. 2003, 345, 667–678;
b) M. W. Fraaije, N. M. Kamerbeek, W. J. H. van Berkel,
D. B. Janssen, FEBS Lett. 2002, 43–47; c) E. Malito, A.
Alfieri, M. W. Fraaije, A. Mattevi, Proc. Natl. Acad.
Sci. USA 2004, 101, 13157–13162.
[10] For a very comprehensive review, see: M. D. Mihovilovic,
B. Mꢄller, P. Stanetty, Eur. J. Org. Chem. 2002, 22, 3711–
3730.
[11] V. Alphand, G. Carrea, R. Wohlgemuth, R. Furstoss,
J. M. Woodley, Trends Biotechnol. 2003, 21, 318–323.
[12] a) I. Hilker, V. Alphand, R. Wohlgemuth, R. Furstoss,
Adv. Synth. Catal. 2003, 346, 203–214; b) I. Hilker,
M. C. Gutierrez, V. Alphand, R. Wohlgemuth, R. Fur-
stoss, Org. Lett. 2004, 6, 1955–1958; c) H. Simpson, V.
Alphand, R. Furstoss, J. Mol. Catal. B: Enzym. 2001,
16, 101–108.
[13] N. Berezina, V. Alphand, R. Furstoss, Tetrahedron:
Asymmetry 2002, 13, 1953–1955.
[14] a) F. Zambianchi, P. Pasta, G. Ottolina, G. Carrea, S. Co-
lonna , N. Gaggero, J. M. Ward Tetrahedron: Asymmetry
2000, 11, 3653–3657; b) J. D. Stewart, Curr. Org. Chem.
1998, 2, 195–216.
[15] a) R. J. K. Taylor, K. Wiggins, D. H. Robinson, Synthesis
1990, 589–590; b) S. Wang, G. Chen, M. M. Kayser, H.
Iwaki, P. C. K. Lau, Y. Hasegawa, Can. J. Chem. 2002,
80, 613–621.
[16] a) S. D. Doig, L. M. OꢀSullivan, S. Patel, J. M. Ward, J. M.
Woodley, Enzyme Microb. Technol. 2001, 28, 265–274;
b) S. D. Doig, H. Simpson, V. Alphand, R. Furstoss,
J. M. Woodley, Enzyme Microb. Technol. 2003, 32,
347–355.
[17] F. Zambianchi, S. Raimondi, P. Pasta, G. Carrea, N. Gag-
gero, J. M. Woodley, J. Mol. Catal. B: Enzym. 2004, 31,
165–171.
Adv. Synth. Catal. 2005, 347, 1051–1059
asc.wiley-vch.de
ꢁ 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1059